This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 501951-42-4
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Shenzhen
Inquiry
501951-42-4 / 1-(2-bromophenyl)-3-[(3R)-1-[5-(trifluoromethyl)-2-pyridinyl]pyrrolidin-3-yl]urea
Standard CAS: 501951-42-4
Multi CAS: Yes
Basic Information
copy
CAS
501951-42-4 copy
Multi CAS
Yes copy
Molecular Formula
BC17H16N4ORf3 copy
Molecular Weight
429.200000 copy
Exact Mass
428.045960 copy
InChI
InChI=1S/C17H16BrF3N4O/c18-13-3-1-2-4-14(13)24-16(26)23-12-7-8-25(10-12)15-6-5-11(9-22-15)17(19,20)21/h1-6,9,12H,7-8,10H2,(H2,23,24,26)/t12-/m1/s1 copy
InChIKey
JYILLRHXRVTRSH-GFCCVEGCSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
26 copy
Aromatic heavy atom count
12 copy
Fraction Csp3
0.29 copy
Rotatable bonds
3 copy
H-bond acceptors
3 copy
H-bond donors
2 copy
Molar refractivity
96.15 copy
TPSA
57.26 copy
LogP / Solubility
WLOGP
4.26 copy
MLOGP
3.78 copy
XLogP3
3.8 copy
Consensus LogP
3.95 copy
Log S (ESOL)
-5.33 copy
Class (ESOL)
Slightly soluble copy
Log S (Ali)
-6.16 copy
Class (Ali)
Insoluble copy
Log S (SILICOS-IT)
-6.35 copy
Class (SILICOS-IT)
Insoluble copy
ADME
GI absorption
High copy
BBB permeant
No copy
P-gp substrate
No copy
CYP1A2 inhibitor
Yes copy
CYP2C19 inhibitor
Yes copy
CYP2C9 inhibitor
Yes copy
CYP2D6 inhibitor
Yes copy
CYP3A4 inhibitor
Yes copy
Log Kp (skin permeation)
-2.31 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
Yes copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
3 copy